Latest Diagnostic tests Stories
Discovery may guide treatment for acute myeloid leukemiaDecoding the DNA of a woman who died of acute myeloid leukemia (AML) has led researchers at Washington University School of Medicine in St. Louis to a gene that they found to be commonly altered in many patients who died quickly of the disease.The findings, if confirmed in larger studies, suggest that a diagnostic test for mutations in the gene could identify AML patients who need more aggressive treatment right from the start. The new...
Press release from PLoS MedicineCommunity Health Workers can safely and effectively provide integrated management of pneumonia and malaria to communities by dispensing amoxicillin to children with non-severe pneumonia and artemether-lumefantrine to children with malaria (after using rapid diagnostic tests). Furthermore, these activities result in a significant increase in the proportion of appropriately-timed antibiotic treatment for non-severe pneumonia and in a significant decrease in...
QUEBEC CITY, Sept. 13 /PRNewswire-FirstCall/ - DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, today reported financial and operation results for the third quarter 2010 ended July 31, 2010. The Company announced a net loss of $1,650,593 or $0.04 per share for the third quarter 2010. These results reflect activities undertaken during this quarter and on-going commitment to develop high-value...
Patients suffering from active tuberculosis (TB) have a specific pattern of genes in their blood, according to a new study from scientists which could lead to better diagnostic tests and improved treatment methods for those suffering from the often deadly infectious disease.The so-called "genetic signature"--discovered by a team of researchers led by Anne O'Garra of the Medical Research Council (MRC)--is present in as many as 10% of the approximately 2 billion people worldwide who...
MISSISSAUGA, Ontario, Aug. 18 /PRNewswire-FirstCall/ -- Dr. Yahia Gawad, CEO of CardioGenics Inc. (OTC Bulletin Board: CGNH), developer of the ultra-sensitive QL Care(TM) Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, took part in an interview on Canada's Business News Network (BNN) on Monday, August 16th to discuss the market potential and technical advantages of the Company's paramagnetic beads and QL Care Analyzer(TM). On the BNN...
QUEBEC CITY, June 9 /PRNewswire-FirstCall/ - DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, today reported financial and operation results for the second quarter 2010 ended April 30, 2010. The Company announced a net loss of $2,204,832 or $0.05 per share per share for the second quarter 2010. These results reflect activities undertaken during this quarter and on-going commitment to develop...
SAN DIEGO, June 6 /PRNewswire/ -- bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago. On June 5(th), scientists from bioTheranostics and the Sarah...
BEIJING, June 4 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced its unaudited financial results for the fourth fiscal quarter ("4Q FY2009") and the full fiscal year ended March 31, 2010 ("FY2009"). 4Q FY2009 Highlights -- Revenues decreased by 29.3% year-over-year to RMB175.7 million (US$25.7 million) but increased by 2.0% sequentially....
DENVER, April 13 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, including innovative products for emerging pathogens and lethal viruses, today announced a major extension of the collaborative effort to combat important viral diseases. The National Institutes of Health (NIH) has awarded a grant totaling $600,000 to Corgenix for the two-year study, which will focus on development of novel,...
QUEBEC CITY and WEST CHESTER, PA, April 12 /PRNewswire-FirstCall/ - DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, has appointed Ms. Valerie Palmieri as President of DiagnoCure Oncology Laboratories, the U.S. subsidiary of DiagnoCure, Inc. Ms. Palmieri brings to DiagnoCure more than 25 years of experience in the laboratory industry, including executive positions responsible for laboratory services,...
